Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Debt Ratio (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Debt Ratio for 4 consecutive years, with 0.81 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio rose 51.55% to 0.81 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.81, a 51.55% increase, with the full-year FY2025 number at 0.81, up 51.55% from a year prior.
  • Debt Ratio was 0.81 for Q4 2025 at Phathom Pharmaceuticals, down from 0.86 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.86 in Q3 2025 to a low of 0.33 in Q4 2023.
  • A 4-year average of 0.56 and a median of 0.54 in 2024 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: plummeted 42.38% in 2023, then surged 89.82% in 2025.
  • Phathom Pharmaceuticals' Debt Ratio stood at 0.58 in 2022, then tumbled by 42.38% to 0.33 in 2023, then skyrocketed by 59.84% to 0.53 in 2024, then skyrocketed by 51.55% to 0.81 in 2025.
  • Per Business Quant, the three most recent readings for PHAT's Debt Ratio are 0.81 (Q4 2025), 0.86 (Q3 2025), and 0.82 (Q2 2025).